Skip to main content
. 2018 Oct 23;37:401–409. doi: 10.1016/j.ebiom.2018.10.045

Table 1.

Allele and genotype distributions of 8 TLR SNPs associated with non-HIV CM in the discovery stage.

SNP Position Gene Genotype Control
All patients
Immunocompetent patients
All patients vs control
Immunocompetent patients vs control
(n = 464) (n = 159) (n = 85) OR (95% CI) p value OR (95% CI) p value
rs5743563 4:38804398 TLR1 T/T (Dominant) 112 (24·1) 55 (34·6) 25 (29·4) 1·66 (1·13–2·46) 0·010 1·31 (0·78–2·19) 0·302
C/T (Over-dominant) 248 (53·5) 74 (46·5) 43 (50·6) 0·76 (0·53–1·09) 0·133 0·89 (0·56–1·42) 0·627
C/C (Recessive) 104 (22·4) 30 (18·9) 17 (20·0) 0·81 (0·51–1·27) 0·348 0·87 (0·49–1·54) 0·622
T (Allelic) 472 (50·9) 184 (57·9) 93 (54·7) 1·33 (1·03–1·72) 0·031 1·17 (0·84–1·62) 0·357
rs5743604 4:38799664 TLR1 C/C (Dominant) 142 (30·6) 37 (23·3) 19 (22·4) 0·69 (0·45–1·04) 0·078 0·65 (0·38–1·13) 0·125
C/T (Over-dominant) 222 (47·8) 75 (47·2) 42 (49·4) 0·97 (0·68–1·40) 0·883 1·06 (0·67–1·69) 0·790
T/T (Recessive) 100 (21·6) 47 (29·6) 24 (28·2) 1·53 (1·02–2·29) 0·040 1·43 (0·85–2·41) 0·175
C (Allelic) 506 (54·5) 149 (46·9) 80 (47·1) 0·74 (0·57–0·95) 0·018 0·74 (0·53–1·03) 0·073
rs3804099 4:153703504 TLR2 T/T (Dominant) 192 (41·4) 81 (50·9) 46 (54·1) 1·47 (1·02–2·11) 0·036 1·67 (1·05–2·66) 0·029
C/T (Over-dominant) 226 (48·7) 65 (40·9) 32 (37·6) 0·73 (0·51–1·05) 0·088 0·64 (0·40–1·02) 0·060
C/C (Recessive) 46 (9·9) 13 (8·2) 7 (8·2) 0·81 (0·43–1·54) 0·518 0·82 (0·36–1·87) 0·630
T (Allelic) 610 (65·7) 227 (71·4) 124 (72·9) 1·30 (0·98–1·72) 0·064 1·41 (0·98–2·02) 0·066
rs1927907 9:117710486 TLR4 G/G (Dominant) 259 (55·8) 99 (62·3) 53 (62·4) 1·31 (0·90–1·89) 0·156 1·31 (0·82–2·11) 0·264
G/A (Over-dominant) 171 (36·9) 44 (27·7) 23 (27·1) 0·66 (0·44–0·97) 0·036 0·64 (0·38–1·06) 0·082
A/A (Recessive) 34 (7·3) 16 (10·1) 9 (10·6) 1·42 (0·76–2·64) 0·273 1·50 (0·69–3·25) 0·304
G (Allelic) 689 (74·2) 242 (76·1) 129 (75·9) 1·11 (0·82–1·49) 0·511 1·09 (0·75–1·60) 0·653
rs3796508 4:38828495 TLR6 G/G (Dominant) 424 (91·4) 136 (85·5) 72 (84·7) 0·56 (0·32–0·97) 0·035 0·52 (0·27–1·03) 0·055
G/A (Over-dominant) 40 (8·6) 23 (14·5) 13 (15·3) 1·79 (1·04–3·10) 0·035 1·91 (0·98–3·75) 0·055
G (Allelic) 888 (95·7) 295 (92·8) 157 (92·4) 0·58 (0·34–0·98) 0·040 0·54 (0·28–1·04) 0·062
rs5743794 4:38831106 TLR6 G/G (Dominant) 157 (33·8) 60 (37·7) 30 (35·3) 1·19 (0·82–1·72) 0·373 1·07 (0·66–1·73) 0·794
G/A (Over-dominant) 226 (48·7) 82 (51·6) 44 (51·8) 1·12 (0·78–1·61) 0·533 1·13 (0·71–1·80) 0·604
A/A (Recessive) 81 (17·5) 17 (10·7) 11 (12·9) 0·57 (0·32–0·99) 0·043 0·70 (0·36–1·38) 0·305
G (Allelic) 540 (58·2) 202 (63·5) 104 (61·2) 1·25 (0·96–1·63) 0·095 1·13 (0·81–1·58) 0·467
rs164637 3:52231199 TLR9 C/C (Dominant) 463 (99·8) 154 (96·9) 82 (96·5) 0·07 (0·01–0·57) 0·005 0·06 (0·01–0·57) 0·013
C/T (Over-dominant) 1 (0·2) 5 (3·1) 3 (3·5) 15·03 (1·74–129·67) 0·005 16·94 (1·74–164·83) 0·013
C (Allelic) 927 (99·9) 313 (98·4) 167 (98·2) 0·07 (0·01–0·58) 0·005 0·06 (0·01–0·58) 0·013
rs352140 3:52222681 TLR9 C/C (Dominant) 184 (39·7) 68 (42·8) 44 (51·8) 1·13 (0·79–1·64) 0·490 1·63 (1·03–2·60) 0·037
C/T (Over-dominant) 224 (48·3) 61 (38·4) 28 (32·9) 0·67 (0·46–0·96) 0·030 0·53 (0·32–0·86) 0·009
T/T (Recessive) 56 (12·1) 30 (18·9) 13 (15·3) 1·69 (1·04–2·75) 0·032 1·32 (0·68–2·53) 0·410
C (Allelic) 592 (63·2) 197 (61·9) 116 (68·2) 0·95 (0·73–1·23) 0·679 1·22 (0·86–1·73) 0·266

Data are n (%). TLR = Toll-like receptor. SNP = single nucleotide polymorphism. HIV = human immunodeficiency virus. CM = cryptococcal meningitis.